Health
New initiative identifies key parameters underlying effective anti-tumor immunity – News-Medical.Net
Neoantigens, tiny markers that arise from cancer mutations, flag cells as cancerous and could be the key to unlocking a new generation of immunotherapies.
Reviewed by Emily Henderson, B.Sc.Oct 9 2020
Neoantigens, tiny markers that arise from cancer mutations, flag cells as cancerous and could be the key to unlocking a new generation of immunotherapies. Targeting the “right” neoantigens – in a cancer vaccine or a cell therapy – has the promise to eliminate a patient’s cancer with minimal side effects. But hundreds of mutations can exist in a tumor, and only some can give rise to neoantigens that can trigger an immune response against cancer. The q…
-
General21 hours agoAshes engulfed by fresh DRS controversy as TV umpire gives Jamie Smith out despite RTS ‘murmur’
-
Noosa News5 hours agoTwo teenagers and two adults rushed to hospital in life-threatening conditions after shocking Lawnton house fire
-
Noosa News5 hours agoFatal traffic crash, Noosa – Sunshine Coast
-
General24 hours ago‘Mother’s Day’ solar storm squeezed Earth’s plasmasphere to one-fifth its size